Literature DB >> 16275945

Immunological markers of the R4 protein of Streptococcus agalactiae.

Johan A Maeland1, Lars Bevanger, Randi Valsoe Lyng.   

Abstract

This study focuses on immunological markers of R4, an important Streptococcus group B (GBS) protein. The results obtained by using rabbit antisera and purified proteins for antigens in enzyme-linked immunosorbent assay-based experiments provided evidence that R4 possesses two antigenic determinants. One of the determinants is shared with the alpha-like protein 3 (Alp3) of GBS, was named R4/Alp3 common, and was expressed by GBS, which possessed the Alp3-encoding gene alp3 or the R4-encoding gene rib. The other antigenic determinant was detected only in rib-positive GBS organisms and was named R4 specific. This determinant probably is an immunological marker unique to the R4 protein. Neither of the antigenic R4 determinants showed serological cross-reactivity with the GBS proteins Calpha, Cbeta, and R3 or with alpha-like protein 2. Of 60 clinical serotype III GBS strains, 56 (93%) isolates possessed the rib gene and 50 (89%) of the rib-positive isolates expressed levels of R4 detectable by antibody-based tests, consistent with R4 expression failure or low-level expression in approximately 10% of rib-positive GBS. alp3 was not detected in type III GBS but was possessed by six of eight type V strains and six of six type VIII strains. All alp3-positive strains were recognized by the R4/Alp3 common antibodies, but none of them were recognized by the R4-specific antibodies. NCTC 9828, a reference strain for R3 and R4, expressed the determinant R4/Alp3 common but not R4 specific. A monoclonal R4 antibody, previously considered to be R4 specific and used in GBS serotyping, targeted R4/Alp3 common and is thus not R4 specific. The results show that failure to discriminate between R4 specific and R4/Alp3 common by antisera designed for GBS serotyping can result in the false identification of Alp3 as R4 or vice versa, whereas anti-R4 antibodies targeting only the determinant R4 specific will detect only R4. Both R4 and Alp3 need further evaluation with respect to the immunobiological function of each distinct antigenic determinant, for instance, with regard to their potential as GBS vaccine components.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16275945      PMCID: PMC1287756          DOI: 10.1128/CDLI.12.11.1305-1310.2005

Source DB:  PubMed          Journal:  Clin Diagn Lab Immunol        ISSN: 1071-412X


  34 in total

1.  Mosaicism in the alpha-like protein genes of group B streptococci.

Authors:  C S Lachenauer; R Creti; J L Michel; L C Madoff
Journal:  Proc Natl Acad Sci U S A       Date:  2000-08-15       Impact factor: 11.205

2.  Molecular profiles of group B streptococcal surface protein antigen genes: relationship to molecular serotypes.

Authors:  Fanrong Kong; Sonia Gowan; Diana Martin; Gregory James; Gwendolyn L Gilbert
Journal:  J Clin Microbiol       Date:  2002-02       Impact factor: 5.948

3.  Antibodies against Streptococcus agalactiae proteins c(alpha) and R4 in sera from pregnant women from Norway and Zimbabwe.

Authors:  S R Moyo; J A Maeland; J Mudzori
Journal:  Clin Diagn Lab Immunol       Date:  2001-11

4.  A Streptococcus agalactiae R protein analysed by polyclonal and monoclonal antibodies.

Authors:  L Bevanger; A I Kvam; J A Maeland
Journal:  APMIS       Date:  1995-10       Impact factor: 3.205

5.  Distribution of serovariants of group B streptococci in isolates from England and Norway.

Authors:  A I Kvam; A Efstratiou; L Bevanger; B D Cookson; I F Marticorena; R C George; J A Maeland
Journal:  J Med Microbiol       Date:  1995-04       Impact factor: 2.472

6.  Molecular analysis of group B protective surface protein, a new cell surface protective antigen of group B streptococci.

Authors:  Sezgin Erdogan; Peter K Fagan; Susanne R Talay; Manfred Rohde; Patricia Ferrieri; Aurea E Flores; Carlos A Guzmán; Mark J Walker; Gursharan S Chhatwal
Journal:  Infect Immun       Date:  2002-02       Impact factor: 3.441

7.  Cross-protection between group A and group B streptococci due to cross-reacting surface proteins.

Authors:  M Stâlhammar-Carlemalm; T Areschoug; C Larsson; G Lindahl
Journal:  J Infect Dis       Date:  2000-06-30       Impact factor: 5.226

8.  Identification of a family of streptococcal surface proteins with extremely repetitive structure.

Authors:  M Wästfelt; M Stâlhammar-Carlemalm; A M Delisse; T Cabezon; G Lindahl
Journal:  J Biol Chem       Date:  1996-08-02       Impact factor: 5.157

9.  Serotype identification of group B streptococci by PCR and sequencing.

Authors:  Fanrong Kong; Sonia Gowan; Diana Martin; Gregory James; Gwendolyn L Gilbert
Journal:  J Clin Microbiol       Date:  2002-01       Impact factor: 5.948

10.  Large, identical, tandem repeating units in the C protein alpha antigen gene, bca, of group B streptococci.

Authors:  J L Michel; L C Madoff; K Olson; D E Kling; D L Kasper; F M Ausubel
Journal:  Proc Natl Acad Sci U S A       Date:  1992-11-01       Impact factor: 11.205

View more
  7 in total

1.  Putative novel surface-exposed Streptococcus agalactiae protein frequently expressed by the group B streptococcus from Zimbabwe.

Authors:  Rooyen T Mavenyengwa; Johan A Maeland; Sylvester R Moyo
Journal:  Clin Vaccine Immunol       Date:  2009-07-08

2.  Streptococcus agalactiae alpha-like protein 1 possesses both cross-reacting and Alp1-specific epitopes.

Authors:  Augusta I Kvam; Rooyen T Mavenyengwa; Andreas Radtke; Johan A Maeland
Journal:  Clin Vaccine Immunol       Date:  2011-06-08

3.  Novel aspects of the Z and R3 antigens of Streptococcus agalactiae revealed by immunological testing.

Authors:  Johan A Maeland; Andreas Radtke; Randi V Lyng; Rooyen T Mavenyengwa
Journal:  Clin Vaccine Immunol       Date:  2013-02-13

Review 4.  Survey of immunological features of the alpha-like proteins of Streptococcus agalactiae.

Authors:  Johan A Maeland; Jan E Afset; Randi V Lyng; Andreas Radtke
Journal:  Clin Vaccine Immunol       Date:  2014-12-24

5.  Distinctive features of surface-anchored proteins of Streptococcus agalactiae strains from Zimbabwe revealed by PCR and dot blotting.

Authors:  Rooyen T Mavenyengwa; Johan A Maeland; Sylvester R Moyo
Journal:  Clin Vaccine Immunol       Date:  2008-07-30

6.  Invasive group B streptococcus (GBS) disease in Norway 1996-2006.

Authors:  H Bergseng; M Rygg; L Bevanger; K Bergh
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2008-06-17       Impact factor: 3.267

7.  Recombinant group B Streptococcus alpha-like protein 3 is an effective immunogen and carrier protein.

Authors:  Hsiao-Hui Yang; Samantha J Mascuch; Lawrence C Madoff; Lawrence C Paoletti
Journal:  Clin Vaccine Immunol       Date:  2008-05-07
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.